Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
about
Therapeutic interventions for Burkitt lymphoma in childrenTherapeutic interventions for Burkitt's lymphoma in childrenComparative analysis of cancer genes in the human and chimpanzee genomes.In vitro human cell line models to predict clinical response to anticancer drugsRole of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cellsValidation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome.Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.Conditional immortalization of human B cells by CD40 ligation.The human genome puzzle - the role of copy number variation in somatic mosaicismEarly embryonic chromosome instability results in stable mosaic pattern in human tissuesExtensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.Co-binding by YY1 identifies the transcriptionally active, highly conserved set of CTCF-bound regions in primate genomesFunctionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation.Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signalingWhole-exome sequencing of DNA from peripheral blood mononuclear cells (PBMC) and EBV-transformed lymphocytes from the same donorSPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1.Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus.The Sonoda-Tajima Cell Collection: a human genetics research resource with emphasis on South American indigenous populationsClinical features of familial adenomas polyps in Chinese and establishment of its immortal lymphocyte cell lines.Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.Different toxic effects of YTX in tumor K-562 and lymphoblastoid cell lines.Establishment & characterization of lymphoblastoid cell lines from patients with multiple primary neoplasms in the upper aero-digestive tract & healthy individuals.Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblastsEstablishment of the MethyLight Assay for Assessing Aging, Cigarette Smoking, and Alcohol ConsumptionCross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virusTelomeres and viruses: common themes of genome maintenance.Molecular approaches towards characterization, monitoring and targeting of viral-associated hematological malignancies.Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.Characterization of DNA methylation and its association with other biological systems in lymphoblastoid cell linesRegulation of telomerase and telomeres: human tumor viruses take control.Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells.Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.Immortalized B cells: a neverending source of antigen-presenting cells for vaccines?Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines.Antibody-based screen for ionizing radiation-dependent changes in the Mammalian proteome for use in biodosimetry.Expression differences by continent of origin point to the immortalization process.Genome-wide identification of expression quantitative trait loci for human telomerase.Epstein-Barr virus and telomerase: from cell immortalization to therapy.
P2860
Q24235495-71829D5B-11B3-451C-848C-6A78363A2731Q24244269-B8B4D22E-4A2E-4438-A726-7E47628DBBC0Q24541311-FA46A87C-CB17-4ADC-B1B8-88CA5A41B298Q27000665-1A6704E1-E4B9-4AA0-BD8B-053386885B10Q28271011-AB7C0DD1-7226-4A6D-87CA-803316F75860Q30653697-DF303596-6568-4EFB-BB34-236BD30B3FADQ33263443-AAC972AF-0518-403B-B20B-DB18DDC5E4E1Q33316020-3B44026C-9271-4E3F-9AB2-47DD344C5EF0Q33350714-F991AF1F-CD4B-46D8-B9C3-C97D898CF4C0Q33541019-D6FD6B1F-DE1A-4209-A141-F255141FEA33Q33749934-712CE93C-07C2-4982-91DB-064763D0085BQ33751432-A1492ACD-600C-4D4D-B1A8-E79A04689C12Q33772124-67376709-C0B7-4DEE-AFE8-0F404E5F76A0Q33802649-C4AD80AB-56EF-4338-BF72-7C2611E1DE06Q34029550-E4EF6DA1-66A8-4ACE-A167-8301719E1759Q34614284-FEF40247-71A3-411C-B3C2-676C05C48869Q34740920-FA515D93-503F-4ED9-950D-445C727BCAF4Q34760052-97D5D12D-0C67-4DBE-BF75-879E75F70BA3Q35397265-140E644D-5245-4FCD-955E-3866620A7498Q35598260-7D4B18C8-6F49-49A2-95A9-FB97D8E888D9Q35641151-6C517707-07F5-46EE-A2EA-6122E0501CECQ35749454-DB622FE5-4270-4417-828F-016FF3070624Q36134466-3D9EF1B6-CB6C-4434-ADAE-FE863655992DQ36207171-044DFA92-5068-48F3-B234-15092D1C03AAQ36249976-41AA691E-CCCF-4540-9F75-5F69396104FAQ36346985-A1E65BDC-C44B-4BC8-97F4-F91816FD8DD3Q36497017-2A042E7E-D91D-4081-9D16-A92CF9092907Q36670930-04CF6D05-25A0-4838-91F3-D6244A52F7DFQ36747951-9433FB1A-0665-495D-960C-09BB8171462CQ36933913-1618629D-9908-41BB-B0A3-D656C0407768Q36973559-30425D53-93E7-4125-A085-64F5F3EFDEC8Q37053343-EED833BD-E503-433C-8D2C-2BE3A7158A1EQ37074285-78588831-032E-4156-AAF5-088CDE5E8296Q37123246-78B53F0B-9FDE-4CF3-9939-9473F882F6E8Q37150312-1ECB1F91-D40F-42D2-B67F-FAB91544911AQ37304493-BBC2A1B6-4B56-4408-9E1C-FA19202BA0F9Q37317611-B423FFE0-EBCA-43E2-A218-4877C568FE41Q37357635-187AA872-FE7B-4ED9-A332-DAC1F92DCD44Q37365023-993EEC1E-9945-469E-ABE1-688F7970AC67Q37619108-0BA56C5E-3E2B-440A-AACB-72D4917BBAB7
P2860
Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Steps involved in immortalizat ...... sformed by Epstein-Barr virus.
@ast
Steps involved in immortalizat ...... sformed by Epstein-Barr virus.
@en
type
label
Steps involved in immortalizat ...... sformed by Epstein-Barr virus.
@ast
Steps involved in immortalizat ...... sformed by Epstein-Barr virus.
@en
prefLabel
Steps involved in immortalizat ...... sformed by Epstein-Barr virus.
@ast
Steps involved in immortalizat ...... sformed by Epstein-Barr virus.
@en
P2093
P1433
P1476
Steps involved in immortalizat ...... sformed by Epstein-Barr virus.
@en
P2093
Hidetoshi Tahara
Masanobu Sugimoto
Toshinori Ide
Yasuhiro Furuichi
P304
P356
10.1158/0008-5472.CAN-04-0079
P407
P577
2004-05-01T00:00:00Z